TMAXTREE Biological completed a financing of 100 million yuan and accelerated the industrialization of high-end life science instruments

Recently, TMAXTREE biological completed nearly 100 million yuan B round of financing. This round of financing is led by Qingkong Jinxin and Tianchuang Capital, followed by Shanshui Green Energy. Three years ago, Qianhai Ark, a famous domestic investment institution, invested in TMAXTREE Biology, which strongly promoted the development of the company. The financing company will further accelerate the development and marketing of high-end scientific instruments in biomedicine and biological manufacturing.

TMAXTREE Biology is a famous domestic life science instrument company that adheres to the original technology research and instrument innovation. It is a "national high-tech enterprise" and a provincial "specialized and special new enterprise". The company was incubated in Wuxi Research Institute of Applied Technology of Tsinghua University. The initial entrepreneurial team is from the biological breeding technology and equipment team of Tsinghua University; the company maintains long-term and deep strategic cooperation with the scientific research teams of Tsinghua University, Chinese Academy of Sciences, Jiangnan University and many other universities.

Company built the plasma biotechnology, microfluidic technology, automatic detection technology and biological sensor technology several core technology system, and the original development of plasma mutation breeding apparatus, high-throughput single-cell microdroplet sorting, microdroplet continuous subculture evolution, biological culture process on-line detector 20 products, including many products belong to the international initiative. After years of research and development, the companys products have realized the full coverage of cell culture, detection and sorting system from leather, micro, ml and upgrade, and creatively realized the connection of different systems, giving greater use of the advantages of different systems; related instruments and equipment combination flexible, wide application, can be widely used in synthetic biology, biological manufacturing, drug development, biological breeding, biological testing and many other fields, to achieve the magnitude of R & D efficiency.

With its outstanding technological innovation, the company has won "China Patent Excellence Award", "First Award of China Light Industry Federation" and "Gold Award of Geneva International Invention Exhibition". The products have passed CE certification, UL certification, and are exported to Japan, United States, Denmark, Singapore, France, Russia and other countries.

The company is always customer-oriented, adhere to equipment innovation, method development and technical services, and strive to provide customers with "hardware equipment + method" complete sets of practical solutions. The team has developed dozens of biosensors for microfluidic systems, and has developed dozens of high-throughput cell culture and sorting methods tailored to different user needs.

The development of the company cannot be separated from the long-term tolerance, trust and support of our customers! TMAXTREE products have served more than 500 customers at home and abroad, and customers have published more than 2,000 articles. The company will adhere to the pain points of the industry and the actual demand as the guidance, to develop customers "buy, use well" products as the goal, continue to optimize products, improve the team service ability, to contribute greater strength to the development of the biological industry.

TMAXTREE biological sincerely thank the investment institutions for their support and trust! Scientific instruments have been compared to the pearl in the crown of high-end manufacturing. The company will continue to uphold the corporate values of "down-to-earth, innovation, customer first and excellence", and together with peer enterprises, let more high-end scientific instruments created by China go global.

Introduction of investment institutions in this round:

Jin Xin capital (Beijing qing control Jin Xin investment management co., LTD.) was founded in 2013, relying on tsinghua production, study and research resources advantage, adhering to the "science and technology, financial for use" concept, deep strategic emerging industries and financial capital market, has become the tsinghua industry to promote the coordinated development of important force, is tsinghua holdings, clear control asset management group member enterprises focus on industrial investment and asset management of professional institutions. Up to now, the total scale of Jinxin Capital Management Fund has exceeded 25 billion yuan.

Tianchuang Capital (Tianjin Venture Capital Management Co., LTD.) was established in 2003. Since its commercial operation, it has been based on profound industry accumulation and government background, based in Tianjin and radiating to the whole country. After 20 years in the field of venture capital, it has managed a total fund scale of 10 billion yuan, invested more than 130 science and technology enterprises, and the listed proportion of the invested enterprises is nearly 20%.

Shanshui Green Energy (Shanshui Green Energy Venture Capital Partnership (limited partnership)) is a fund of Xingyuan Capital. Wuxi Xingyuan Private Equity Fund Management Co., Ltd. is a state-owned capital holding and mixed ownership venture capital platform in Wuxi High-tech Zone, and is the vice president unit of Wuxi High-tech Zone Venture Capital Promotion Association. Since its establishment, Xingyuan Capital has been deeply engaged in the field of equity investment, making enabling investment in high-end manufacturing, biomedicine, new energy and other strategic emerging industries in the Yangtze River Delta region, covering the whole ife cycle of science and technology enterprises. It has grown into a venture capital brand with a certain asset management scale and industry influence in the region.